Pharma & biotech · RNAi therapeutics
Alnylam Pharmaceuticals
About Alnylam Pharmaceuticals
Alnylam markets RNA interference medicines, and its commercial organization runs as business units with field teams of their own: TTR, which promotes AMVUTTRA (vutrisiran) to the physicians and accounts that treat transthyretin amyloidosis, now including its cardiomyopathy form, and Global Rare, which sells GIVLAARI for acute hepatic porphyria and OXLUMO for primary hyperoxaluria type 1. In the US the frontline seat is the business account executive, who carries territory targets across a multi-state patch (Upstate New York with Central Pennsylvania, Alaska with Washington and Northern Oregon, Northern California with Southern Oregon, Florida from Orlando to Jacksonville) by finding undiagnosed patients through their doctors, and who reports to a regional business director coaching a team of them. Around that field force sit account and access seats: health systems directors who set strategy and contracting with priority health systems and organized customers under a senior director of strategic accounts, and field reimbursement managers and associate directors who teach practices and infusion sites buy-and-bill, prior authorization and payer rules. Cambridge, Massachusetts holds the commercial operations, incentive compensation, field force effectiveness and pricing and contracting analytics leaders, plus a corporate development director who negotiates licensing deals. Abroad, key account managers in Germany and Spain work the treatment centers of an assigned territory toward pre- and post-launch targets under area sales managers, and a senior director in Zug leads the Global Rare field business leaders and their KAMs across a western cluster of international markets.
Typical pay, live
, SalesJobs.Now shows 17 open Alnylam Pharmaceuticals sales roles; the postings mostly run from $170k to $276k a year, with $189k in the middle.
Alnylam Pharmaceuticals sales openings
Board read 14 Nov 2026, 00:06 UTCComparable sales openings elsewhere
The same sales role at other companies.
Enterprise Account Executive (opens the job details)
AlwaysHired · AE · San Francisco, CA; New York, NY· 1mo agoDetails
$130,000–$165,000/yrSenior Account Executive (opens the job details)
AlwaysHired · AE · El Segundo / Los Angeles, CA· 1w agoDetails
$100,000–$140,000/yrSMB/Mid-Market Account Executive (opens the job details)
AlwaysHired · AE · San Francisco, CA· 1w agoDetails
$130,000–$160,000/yrAccount Executive (Mid-Market) (opens the job details)
AlwaysHired · AE · Remote· 1w agoDetails
$120,000–$140,000/yr
If one of these employers pays a referral fee, it comes from them when you apply here, and your offer stays exactly the same.
- $160,700–$217,300/yr
- $144,500–$195,500/yr
- $160,700–$217,300/yr
- $160,700–$217,300/yr
- $144,500–$195,500/yr
- $144,500–$195,500/yr
- $160,700–$217,300/yr
- $160,700–$217,300/yr
Key Account Manager, Barcelona (opens the job details)
Account management · Barcelona, Spain· 1mo agoDetails
Health Systems Director (opens the job details)
Account management · Chicago, IL, United States· 2w agoDetails
$204,000–$276,000/yr
SalesJobs.Now is free for job seekers. Some links here pay us: a job ad network pays for a click on one of its sponsored jobs, a recruiting firm pays a referral fee when someone who came from here is hired, and a career tool pays a commission when you buy it. That costs you nothing and never lowers what you are paid. Roles whose links pay us can be placed higher in a list. "Featured roles" are openings an employer picked during a free trial with us; no employer can pay for that spot.
Sponsored jobs from job networks, which pay SalesJobs.Now when you click one.
Alnylam Pharmaceuticals openings by country
Where its sales openings take applicants, country by country.
Alnylam Pharmaceuticals sales openings in your inbox
We look at Alnylam Pharmaceuticals's careers page every 10 hours. Once a week you get its newest sales openings, plus close matches at other companies. Free, and one click stops it.
Alnylam Pharmaceuticals as an employer
RNAi therapeutics company founded in 2002 whose sales hiring is specialty field sellers, account and reimbursement seats and commercial operations for its amyloidosis and rare-disease medicines in the US and Europe. Posted pay: $170k–$276k/yr, midpoint $189k/yr.
Hiring now, with pay read from the salaries its own postings state17 sales openings at Alnylam Pharmaceuticals, as its own board showed them 14 Nov 2026.
US sellers earn a base salary with an annual short-term incentive (sales incentive or bonus) and an annual long-term incentive such as equity; the European postings do not describe pay.
Right now its 17 open sales roles are posted in Chicago (2), Minneapolis (2), Alabama (1), Barcelona (1), Kansas City (1) and 2 more places. Read from its postings on 30 Oct 2026: US field territories: Chicago, Minneapolis and the Great Lakes North (the Dakotas, Minnesota, Iowa and Wisconsin), Upstate New York and Central Pennsylvania, the Pacific Northwest (Alaska, Washington, Northern Oregon), Northern California and Southern Oregon, South Alabama, Orlando and Jacksonville in Florida, and a South Central region around Atlanta, Alabama, Louisiana, Arkansas and Mississippi, with operations and corporate development roles in Cambridge, Massachusetts; abroad Germany (the Northeast, Bonn and Mainz, Duisburg and Düsseldorf), Barcelona and Zug, Switzerland.
Pay at Alnylam Pharmaceuticals
From today's postings, 14 Nov 2026Midpoint $189k/yr across 13 openings with posted pay. Posted figures range from $123k/yr to $322k/yr.
Based on 13 distinct posted pay ranges, at this company, every range put on a yearly basis (a rate per hour × 2,080 hours). 4 of the 17 openings here list no pay.
| Sales role | Openings | Typical base | Top posted |
|---|---|---|---|
| AE | 8 | $170k–$217k/yr | $217k/yr |
| Account management | 6 | $175k–$268k/yr | $276k/yr |
| Sales leadership | 3 | $204k–$322k/yr2 salaries | $322k/yr |
Best-paid Alnylam Pharmaceuticals openings on the board
All 17 of its openings, sorted by paySenior Director, US Strategic Accounts (opens the job details)
Sales leadership · United States· 1mo agoDetails
$238,000–$322,000/yrHealth Systems Director (opens the job details)
Account management · Chicago, IL, United States· 2w agoDetails
$204,000–$276,000/yrRegional Business Director, TTR - South Central (Atlanta, AL, LA, AR, MS) (opens the job details)
Sales leadership · United States· 1mo agoDetails
$204,000–$276,000/yrAssociate Director, Field Reimbursement - Great Lakes North (opens the job details)
Account management · Minneapolis, MN, United States· 1w agoDetails
$174,300–$235,700/yr- $160,700–$217,300/yr
Typical means from the 25th percentile of the midpoints of posted ranges (each counted as yearly pay, a rate per hour at 2,080 hours) to the 90th percentile of their top ends, the yardstick behind every list on this site. How we source and grade each salary figure.
Sales roles Alnylam Pharmaceuticals hires for
Click a role to see what the job involves, which companies want it and what it posts for pay everywhere.
Breaking into sales? Read the guides first or see what every company posts for pay.
From the forum
Ask salespeople what Alnylam Pharmaceuticals is like from the inside: comp, quota, the interview loop.
Alnylam Pharmaceuticals: what candidates ask before applying
Is Alnylam Pharmaceuticals a good company to sell for?
RNAi therapeutics company founded in 2002 whose sales hiring is specialty field sellers, account and reimbursement seats and commercial operations for its amyloidosis and rare-disease medicines in the US and Europe.
Is Alnylam Pharmaceuticals still an active employer?
Yes. RNAi therapeutics company founded in 2002 whose sales hiring is specialty field sellers, account and reimbursement seats and commercial operations for its amyloidosis and rare-disease medicines in the US and Europe. How its pay is structured: US sellers earn a base salary with an annual short-term incentive (sales incentive or bonus) and an annual long-term incentive such as equity; the European postings do not describe pay.
What does a sales job at Alnylam Pharmaceuticals pay?
On Alnylam Pharmaceuticals's board today, the 13 openings that post pay put the typical band at $170k–$276k/yr and the midpoint at $189k/yr. Posted figures range from $123k/yr up to $322k/yr.
Is selling for Alnylam Pharmaceuticals worth it?
Posted pay at Alnylam Pharmaceuticals: $170k–$276k/yr, midpoint $189k/yr. Pharma sales suit reps who build trust with prescribers over many visits and keep to what a drug's label allows them to say.
How is Alnylam Pharmaceuticals's sales comp put together?
US sellers earn a base salary with an annual short-term incentive (sales incentive or bonus) and an annual long-term incentive such as equity; the European postings do not describe pay.
Where are Alnylam Pharmaceuticals's sales roles based?
Right now its 17 open sales roles are posted in Chicago (2), Minneapolis (2), Alabama (1), Barcelona (1), Kansas City (1) and 2 more places. Read from its postings on 30 Oct 2026: US field territories: Chicago, Minneapolis and the Great Lakes North (the Dakotas, Minnesota, Iowa and Wisconsin), Upstate New York and Central Pennsylvania, the Pacific Northwest (Alaska, Washington, Northern Oregon), Northern California and Southern Oregon, South Alabama, Orlando and Jacksonville in Florida, and a South Central region around Atlanta, Alabama, Louisiana, Arkansas and Mississippi, with operations and corporate development roles in Cambridge, Massachusetts; abroad Germany (the Northeast, Bonn and Mainz, Duisburg and Düsseldorf), Barcelona and Zug, Switzerland.
Weigh Alnylam Pharmaceuticals against
Neuroscience biotech preparing the US launch of azetukalner, a Kv7 potassium channel opener for focal onset seizures now filed with the FDA, to neurologists, epilepsy centers, health systems, commercial and government payers.
$253k–$345k/yrTypical pay, live
A clinical-stage gene therapy company in Rockville, Maryland, built on its NAV AAV vector platform, preparing to launch RGX-202 for Duchenne muscular dystrophy to neuromuscular treatment centers and the payers that cover them.
Stated per postingStated by the company
Develops avexitide for post-bariatric hypoglycemia, plus programs in Wolfram syndrome and ALS, and is standing up the US field force that would sell the PBH drug.
$239k–$253k/yrTypical pay, live
Clinical-stage oncology drug developer preparing to sell varegacestat, a gamma secretase inhibitor for desmoid tumors under FDA review, to US oncologists, sarcoma specialists, health plans and PBMs.
$223k–$235k/yrTypical pay, liveCompanies are listed by what an application there is worth to you, and one that pays us a fee for hires sent from here gets a lift in that order; the fee never touches the base or OTE a company offers.
Hiring salespeople at Alnylam Pharmaceuticals? See how to put your openings in front of the sellers who browse this board.